Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FYA2S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,363
Award facts
- Contract value 100% obligated
- $12,363.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,363.03 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose, 2 pens/mL, with an ultimate completion date of December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp serves as a critical prime vendor for federal medical procurement, supplying pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent IDC encompasses a comprehensive global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Cosentyx, a biologic immunosuppressant used to treat autoimmune conditions, reflects the company's role in fulfilling ongoing pharmaceutical needs for the Defense Health Agency and other federal healthcare systems. The contract award demonstrates AmerisourceBergen's capability to meet federal procurement requirements through competitive, open-market competition within DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FYA2S?
SPE2DR26FYA2S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FYA2S worth?
The government has obligated $12,363 on SPE2DR26FYA2S.
Is contract SPE2DR26FYA2S an order under another contract?
Yes. SPE2DR26FYA2S is a delivery order under SPE2DR25D6044, an indefinite delivery contract.
Was contract SPE2DR26FYA2S competed?
The extent of competition for SPE2DR26FYA2S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award